Hengrui Pharma, Braveheart Bio Report Positive Phase 2 Results
30 Mar 2026 //
PR NEWSWIRE
Braveheart Bio at TD Cowen 46th Annual Health Care Conference
23 Feb 2026 //
PR NEWSWIRE
Braveheart Bio Strengthens Leadership For Global Phase 3
05 Feb 2026 //
PR NEWSWIRE
Braveheart Pays $65 M to Challenge BMS for Heart Disease Market
05 Sep 2025 //
FIERCE BIOTECH

Market Place
Sourcing Support